Skip to main content

Presight Capital — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

62
Companies
$1.0B
Total invested
$16.3M
Avg. check
56
Industries
Biotechnology 11Health Care 9Marketplace 3Therapeutics 3Artificial Intelligence (AI) 3Software 3+50 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 62
TRIP
September 2026

TRIP is a CBD brand that sells wellness products infused with adaptogens.

Cannabis · London$40.0M Undisclosed
Peek
November 2025

Peek is a travel-tech platform designed for booking tours and provides software for tour and activity operators to manage their businesses.

Internet · San Francisco$70.0M Series D
Angiex
November 2025

Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics.

Biotechnology · Cambridge$31.0M Undisclosed
Peptilogics
October 2025

Peptilogics is a clinical-stage therapeutics company that develops peptide-based therapeutics using AI and computational biology.

Artificial Intelligence (AI) · Pittsburgh$78.0M Series B
Tern Group
September 2025

Tern Group is an AI Platform to hire and relocate top healthcare talents globally, faster and cheaper.

Artificial Intelligence (AI) · London$24.0M Series A
Delix Therapeutics
September 2025

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Biotechnology · Boston$25.0M Series B
General Fusion
August 2025

General Fusion provides commercial fusion energy by developing a magnetized target fusion (MTF) technology.

Energy · Richmond$21.6M Venture - Series Unknown
Syfe
June 2025

Syfe is a digital investment platform that offers a range of investment solutions tailored for both novice and experienced investors.

Financial Services · Singapore$53.0M Series C
FORME
March 2025

FORME is a digital fitness platformy that offers smart home gyms and virtual personal training services.

Fitness · Los Angeles$3.6M Post-IPO Debt
Needle
March 2025

Needle operates as an AI-driven platform for search and agent creation.

Artificial Intelligence (AI) · Wilmington$2.1M Seed
Transmutex
January 2025

Transmutex will reduce stockpile of nuclear waste by 99% while producing profitable carbon-free energy.

Energy · Vernier$4.3M Grant
Parker
November 2024

Parker offers corporate credit cards to help e-commerce businesses pay expenses and manage their finances.

Banking · New York$20.0M Series B
EnClear Therapies
September 2024

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

Biotechnology · Cambridge$5.0M Grant
TMRW Life Sciences
July 2024

TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.

Biotechnology · New York$28.2M Series D
Hoxton Farms
June 2024

Based in London, UK, Hoxton Farms is growing cultivated fat as an ingredient for the meat alternatives industry.

Alternative Protein · LondonSeries A
Perfect Day
January 2024

Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow’s milk.

Bakery · Berkeley$90.0M Series E
Pantheon Design
December 2023

Pantheon design makes 3D printing systems that are industry leading in speed, while delivering end use quality parts and reliability

3D Printing · Vancouver$500K Convertible Note
Rational Vaccines
October 2023

Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.

Biotechnology · Woburn$2.8M Grant
Centenara Labs
September 2023

Centenara Labs is an integrated biotechnology platform company that invests in people and ideas to develop therapies.

Biotechnology · SchlierenDebt Financing
Karma Biotechnologies
May 2023

Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.

Biotechnology · Torrance$31K Seed
Deciduous Therapeutics
December 2022

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

Biopharma · San Francisco$10.0M Seed
Joro
December 2022

Carbon tracking and offsetting app

Apps · OaklandSeed
RARIO
October 2022

RARIO is a non-fungible token (NFT) marketplace that makes the digital collectible revolution accessible to every fan.

Blockchain · SingaporeUndisclosed
thirdweb
August 2022

thirdweb is an end to end developer tool accelerating teams building web3 apps, games, tokens, NFTs, marketplaces, DAOs and more.

Blockchain · San Francisco$24.0M Series A

Where Presight Capital invests

Biotechnology11
Health Care9
Marketplace3
Therapeutics3
Artificial Intelligence (AI)3
Software3

About Presight Capital's portfolio

How many companies has Presight Capital invested in?▸

Presight Capital has invested in 62 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Presight Capital invest in?▸

Presight Capital's top investment sectors include Biotechnology, Health Care, Marketplace, Therapeutics, Artificial Intelligence (AI). The firm invests across 56 different industry categories.

What is Presight Capital's largest investment?▸

Among tracked funding rounds, Perfect Day received $90.0M in a Series E round. Presight Capital's total known invested capital is $1.0B.

What is the average investment size for Presight Capital?▸

Presight Capital's average investment size is $16.3M across its portfolio of 62 companies.

What are Presight Capital's most recent investments?▸

Recent Presight Capital portfolio additions include TRIP, Peek, Angiex, Peptilogics, Tern Group. These companies were founded in 2020 or later.

Reach the founders behind these 62 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →